Page 3 - ஜய்துச் ஆரோக்கியம் வரையறுக்கப்பட்டவை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஜய்துச் ஆரோக்கியம் வரையறுக்கப்பட்டவை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஜய்துச் ஆரோக்கியம் வரையறுக்கப்பட்டவை Today - Breaking & Trending Today

PM asks vaccine companies to ramp up production, assures logistical support

PM asks vaccine companies to ramp up production, assures logistical support
SECTIONS
Last Updated: Apr 21, 2021, 07:48 AM IST
Share
Synopsis
In May 2020, Modi had directed officials not to differentiate between the public and private sectors and said the government should work as investor, incubator, evaluator and buyer of vaccines.
On Tuesday, the Prime Minister praised the efforts of vaccine manufacturers in developing vaccines in record time and producing them on a large scale to meet the requirement in India and for export to some countries.
Prime Minister Narendra Modi asked vaccine manufacturers to step up production to meet increasing demand a day after the government said all people 18 and above will be eligible for Covid jabs from May 1. He assured companies that the Centre will provide logistical support, including speedy and scientific approvals. ....

Gennova Biopharma , Pankaj Patel , Narendra Modi , Krishna Ella , Satish Reddy , Sanjay Singh , Adar Poonawala , Mahima Datta , Mission Covid Suraksha , Serum Institute Of India , Prime Minister Narendra Modi , Prime Minister , Mission Covid , Serum Institute , Bharat Biotech , Vaccine Manufacturers , பங்கஜ் படேல் , நரேந்திர மோடி , கிருஷ்ணா எல்லா , சத்தீஷ் சிவப்பு , சஞ்சய் சிங் , அடார் பூனாவள , மஹிமா தத்தா , சீரம் நிறுவனம் ஆஃப் இந்தியா , ப்ரைம் அமைச்சர் நரேந்திர மோடி , ப்ரைம் அமைச்சர் ,

Zydus Cadila seeks DCGI approval for use of PegIFN in treating COVID-19

Zydus Cadila announced that its Phase III clinical trials with Pegylated Interferon Alpha 2b, PegiHepTM has shown promising results in treating COVID-19. In what could be a breakthrough in the disease management of COVID-19, the interim results indicate that PegIFN when administered early on, could help patients recover faster and avoiding much of the complications seen in the advanced stages of the disease. PegIFN in COVID19 has several add-on advantages compared to other anti-viral agents. The treatment regimen would be less cumbersome and more affordable for patients as Pegylated Interferon Alpha 2b, is a single dose regimen.
It would also ensure better compliance. PegIFN has very well-established safety with multiple doses in chronic hepatitis B and C patients since many years. Patients on Pegylated Interferon Alpha 2b during the trial also showed lesser need for supplemental oxygen, clearly indicating that it was able to control respiratory distress and failure which has ....

Zydus Cadila , Pegylated Interferon Alpha , Signal Transduction , Targeted Therapy , Capital Market , Antiviral Drugs , Medical Specialties , Pegylated Interferon , Cadila Healthcare , Covid 19 Drug Repurposing Research , Generic Pharmaceuticals , Chronic Hepatitis B , ஜய்துச் காடிலா , சமிக்ஞை கடத்தல் , இலக்கு சிகிச்சை , மூலதனம் சந்தை , மருத்துவ சிறப்பு , காடிலா சுகாதாரம் , ஜெநெரிக் மருந்துகள் ,

Zydus Cadila seeks DCGI nod for use of hepatitis drug for Covid-19 treatment | India News

Representative image (AFP)
NEW DELHI: Drug firm Zydus Cadila on Monday said it has sought approval from the domestic drug regulator drugs controller general of India (DCGI) for additional indication of its hepatitis drug Pegylated Interferon Alpha-2b for treating Covid-19.
Phase-III clinical trials with Pegylated Interferon Alpha 2b, which company sells under the brand name PegiHep has shown promising results in treating Covid-19, Zydus Cadila said in a statement.
The interim results indicate that the drug when administered early on, could help patients recover faster and avoid much of the complications seen in the advanced stages of the disease, it added. ....

United States , Zydus Cadila , Sharvil Patel , Zydus Group , Pegylated Interferon , Pegylated Interferon Alpha , Indian Innovation , Cadila Healthcare , India News , India News Today , Today News , Google News , Breaking News , ஒன்றுபட்டது மாநிலங்களில் , ஜய்துச் காடிலா , ஷார்வில் படேல் , ஜய்துச் குழு , இந்தியன் கண்டுபிடிப்பு , காடிலா சுகாதாரம் , இந்தியா செய்தி , இந்தியா செய்தி இன்று , இன்று செய்தி , கூகிள் செய்தி , உடைத்தல் செய்தி ,

Zydus seeks DCGI approval for using PegIFN in COVID-19 treatment

91.15% of patients treated with PegIFN were RT PCR negative by day 7 as compared to
78.90% on the standard of care (SOC) arm ....

Pegihep Peg , Zydus Cadila , Sharvil Patel , Cadila Healthcare Ltd , Pegylated Interferon Alpha , Signal Transduction , Targeted Therapy , Managing Director , Pegylated Interferon , Indian Innovation , Covid 19 , ஜய்துச் காடிலா , ஷார்வில் படேல் , காடிலா சுகாதாரம் லிமிடெட் , சமிக்ஞை கடத்தல் , இலக்கு சிகிச்சை , நிர்வகித்தல் இயக்குனர் , இந்தியன் கண்டுபிடிப்பு ,

BPCL share price: Stocks in the news: BPCL, Tata Motors, Cadila Healthcare, Max Financial & Godrej Properties

Explore Now
Nifty futures on the Singapore Exchange traded 73.50 points, or 0.49 per cent, higher at 15,055.50 in signs that Dalal Street was headed for a positive start on Tuesday. Here are a few stocks which may buzz the most in today s trade:
BPCL) is likely to sell up to 8.68 crore shares, or 4 per cent of the company equity, through a block deal on Tuesday. The company, according to bankers, has set a floor price of Rs 435 per share, a 6.8 per cent discount to Monday’s closing price of Rs 467.
Zydus Cadila is likely to release the phase III data of its Covid-19 vaccine by the end of this month or early next month, a senior company executive said. ....

Bharti Airtel , Max Ventures Investment Holdings , Godrej Properties , Max Financial Services , Tata Motors , Business Analytics Services , Telecom Department On , Max Financial Services On , Bharat Petroleum Corporation , Singapore Exchange , Dalal Street , State Owned Bharat Petroleum Corporation , Vodafone Idea , Telecom Department , Reliance Jio , Financial Services , Analytics Services Limited , Companies Act , Design Arena , Magic Aadhaar , Artificial Intelligence Powered , Tata Motors Share Price , Pre Market , Bpcl Share Price , Tata Motors Limited , பாரதி ஏர்டெல் ,